Cargando…
Prevention of autoimmune diabetes in non-obese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide
The role of antigen presentation as a possible mechanism underlying major histocompatibility complex (MHC) association of autoimmune disease has been studied in non-obese diabetic (NOD) mice. By screening for inhibition of antigen presentation to NOD T cell hybridoma, we have selected a synthetic pe...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191014/ https://www.ncbi.nlm.nih.gov/pubmed/8478620 |
Ejemplares similares
-
Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice
Publicado: (1993) -
Weak Proinsulin Peptide–Major Histocompatibility Complexes Are Targeted in Autoimmune Diabetes in Mice
por: Levisetti, Matteo G., et al.
Publicado: (2008) -
Role of major histocompatibility complex class II in the development of autoimmune type 1 diabetes and thyroiditis in rats
por: Yokoi, N, et al.
Publicado: (2012) -
The Contribution of Major Histocompatibility Complex Class II Genes to an Association with Autoimmune Diseases
por: Zakharova, M. Yu., et al.
Publicado: (2019) -
Prevention of nephritis in major histocompatibility complex class II- deficient MRL-lpr mice
Publicado: (1994)